Structure formed by strep protein can trigger toxic shock

Apr 06, 2011
M1 joints (red) and fibrinogen struts (green) form a scaffold. Dense assemblies trigger a pathological response that can lead to toxic shock. Higher resolution image and an additional version with white background available here: http://physicalsciences.ucsd.edu/press/. Credit: Partho Ghosh lab/UC San Diego

Infection with some strains of strep turn deadly when a protein found on their surface triggers a widespread inflammatory reaction.

In a report published April 7 in the journal Nature, researchers describe the precise architecture of a superstructure formed when the bacterial protein called M1 links with a host protein, fibrinogen, that is normally involved in clotting blood.

The proteins form scaffolds with M1 joints and fibrinogen struts that assemble into dense superstructures. Frontline called neutrophils mistake these thick networks for and overreact, releasing a chemical signal that can dilate vessels to the point where they leak, the team reports.

This video is not supported by your browser at this time.
M1 joints (red) and fibrinogen struts (blue) form a scaffold. Dense assemblies trigger a pathological response that can lead to toxic shock. Credit: Partho Ghosh lab

"We knew that M1 plus fibrinogen was inflammatory, but how was unknown. By determining the structure of this complex, we were able to identify the characteristics that lead to a sepsis response," said Partho Ghosh, Ph.D., professor of chemistry and biochemistry at the University of California, San Diego who studies the structure of virulence factors and led this project.

Ghosh and colleagues found that the density of the M1-fibrinogen structure was a critical characteristic. Looser structures or separate fibers formed by altered versions of M1 failed to trigger a pathological response.

"This research provides the first snapshot of the interaction between this key bacterial virulence factor and its human target at the ," said Victor Nizet, M.D., professor of pediatrics and pharmacy and a co-author of the report.

Difficult to treat once they set in, the leaking blood vessels and of strep-induced toxic shock prove fatal for 30 percent of patients. Ghosh and Nizet have a long-standing collaboration aimed at designing treatments to counteract the toxic effects of strep .

Explore further: Jumping hurdles in the RNA world

More information: Streptococcal M1 protein constructs a pathological host fibrinogen network. DOI:10.1038/nature09967

Related Stories

How flesh-eating bacteria attack the body's immune system

Aug 13, 2008

"Flesh-eating" or "Strep" bacteria are able to survive and spread in the body by degrading a key immune defense molecule, according to researchers at the University of California, San Diego, School of Medicine and Skaggs ...

Inhibiting blood to save the brain

Mar 22, 2007

A fibrous protein called fibrinogen, found in circulating blood and important in blood clotting, can promote multiple sclerosis (MS) when it leaks from the blood into the brain, triggering inflammation that leads to MS-related ...

Blood protein triggers scars in the brain after injury

Apr 27, 2010

A protein called fibrinogen that is known to help form blood clots also triggers scar formation in the brain and spinal cord, according to new research in the April 28 issue of the Journal of Neuroscience. Resear ...

A novel target for therapeutics against Staph infection

Nov 28, 2008

Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology, and the University of Edinburgh have uncovered how a bacterial pathogen interacts with the blood coagulation protein fibrinogen to ...

Recommended for you

Molecules that came in handy for first life on Earth

25 minutes ago

For the first time, chemists have successfully produced amino acid-like molecules that all have the same 'handedness', from simple building blocks and in a single test tube. Could this be how life started. ...

Jumping hurdles in the RNA world

Nov 21, 2014

Astrobiologists have shown that the formation of RNA from prebiotic reactions may not be as problematic as scientists once thought.

New computer model sets new precedent in drug discovery

Nov 18, 2014

A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects - a challenge that has ...

Finding new ways to make drugs

Nov 18, 2014

Chemists have developed a revolutionary new way to manufacture natural chemicals and used it to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.